Since it is interesting to investigate the role of the type 2 inflammatory response in the development of drusen in MPN patients, we compared IL-4, IL-13 and IL-33 serum levels in MPNd and MPNn (Table 2). The gene discussed is IL13; the disease is myeloproliferative neoplasm.